SCHEMBL22485681

SCHEMBL22485681

C=Cc1ccc(N(c2ccc(OC)cc2)c2ccc3c(c2)c2cc(N(c4ccc(C=C)cc4)c4ccc(OC)cc4)ccc2n3Cc2c3ccccc3c(Cn3c4ccc(N(c5ccc(C=C)cc5)c5ccc(OC)cc5)cc4c4cc(N(c5ccc(C=C)cc5)c5ccc(OC)cc5)ccc43)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.41
▸ PTGER4 P35408 2/20 0.41
▸ P2RX4 Q99571 1/20 0.40
▸ TSPO P30536 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ PER2 O15055 1/20 0.38
▸ CRY1 Q16526 1/20 0.38
▸ CRY2 Q49AN0 1/20 0.38
▸ SRC P12931 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ HPGD P15428 3/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ GRIK2 Q13002 2/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ MEN1 O00255 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31165259 0.82 P2RX4 (0.44) MAPTP2RX4TSPOKDM4EPER2
SCHEMBL22486701 0.81 MAPT (0.46) MAPTPTGER4KDM4EALDH1A1SMN1; SMN2
SCHEMBL30822886 0.80 P2RX4 (0.45) MAPTPTGER4P2RX4TSPOKDM4E
SCHEMBL18083988 0.80 GRIK2 (0.46) MAPTPTGER4P2RX4TSPOKDM4E
SCHEMBL18083987 0.80 P2RX4 (0.45) MAPTPTGER4P2RX4TSPOKDM4E
SCHEMBL17414871 0.78 P2RX4 (0.53) MAPTP2RX4ALDH1A1KMT2AHTT
SCHEMBL18083981 0.78 GRIK2 (0.43) MAPTPTGER4P2RX4TSPOKDM4E
SCHEMBL22486379 0.78 KDM4E (0.38) MAPTPTGER4KDM4EALDH1A1CYP1A2
SCHEMBL18084007 0.77 P2RX4 (0.54) MAPTPTGER4P2RX4KDM4EALDH1A1
SCHEMBL18083995 0.77 P2RX4 (0.47) MAPTPTGER4P2RX4TSPOKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200308149-A1 FUSED AND CROSS-LINKABLE IONIC HOLE TRANSPORT MATERIALS FOR PEROVSKITE SOLAR CELLS ENERGY EVERYWHERE, INC. (US) 2020-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308149-A1 FUSED AND CROSS-LINKABLE IONIC HOLE TRANSPORT MATERIALS FOR PEROVSKITE SOLAR CELLS SLC43A1, SLC7A5, SUN2 MAPT 491/4885PTGER4 2825/4885P2RX4 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback